BRAIDWELL LP

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 1920938 STAMFORD, CT

Position in RYTM

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$27,015,317

+$13,112,813 QoQ

Shares Held

310,628

-63.2% QoQ

Ownership

0.453%

of shares outstanding

% of Portfolio

1.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

BRAIDWELL LP holds $1,648,117,197 across 48 Biotechnology names. RYTM ranks #25 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CAI	Caris Life Sciences, Inc.	8,009,447	$143,208,912
2	CNTA	Centessa Pharmaceuticals plc	1,986,768	$78,914,424
3	XENE	Xenon Pharmaceuticals Inc.	1,338,452	$77,830,983
4	DNTH	Dianthus Therapeutics, Inc. /DE/	899,364	$75,474,626
5	EWTX	Edgewise Therapeutics, Inc.	2,347,583	$73,948,864
6	NUVL	Nuvalent, Inc.	700,429	$71,758,951
7	KOD	Kodiak Sciences Inc.	1,818,665	$69,327,509
8	CGON	CG Oncology, Inc.	984,783	$66,650,113

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$27,015,317	310,628	-63.2%	Shares	Sole	2026-05-15
2023-06-30	$13,902,504	843,087	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.